In this episode, I speak with Daniel Kapfer, CEO of Jenly AI, about how AI is reshaping regulatory reporting and PV processes. We discuss real use cases, quick efficiency wins, and the risks you can’t ignore, including AI hallucinations and validation challenges.

The key message: AI can accelerate pharmacovigilance, but humans remain essential. The future is “human in the loop.”

What you’ll learn:
• Where AI delivers the biggest impact in PV
• How to use tools like Copilot for quick wins
• How to manage AI risks and hallucinations
• Why human expertise is still critical

📩 Contact Daniel Kapfer:
Website: www.jenly.ai
Email: [email protected]